Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Epoetin Alfa 40000 UNT/ML
DRUG
2 trials
Sponsors
Bio Sidus SA
, Australian and New Zealand Intensive Care Research Centre
Conditions
Anemia
Blunt Injury
Major Trauma
Multiple Trauma
Penetrating Injury
Trauma
Traumatic Brain Injury
Traumatic Injury
+1 more
Phase 1
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
Completed
NCT03822884
Bio Sidus SA
Anemia
Start: 2016-09-30
End: 2016-12-31
Updated: 2020-02-12
Phase 3
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
Recruiting
NCT04588311
Australian and New Zealand Intensive Care Research Centre
Blunt Injury, Major Trauma, Multiple Trauma +5
Start: 2020-11-09
End: 2027-08-31
Target: 2500
Updated: 2025-07-16